#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Supportive care for men with prostate cancer: why are the trials not working? A systematic review and recommendations for future trials


Abstract:
Men with prostate cancer are likely to have a long illness and experience psychological distress for which supportive care may be helpful. This systematic review describes the evidence for effectiveness and cost-effectiveness of supportive care for men with prostate cancer, taking into account treatment pathway and components of interventions. MEDLINE, EMBASE, CINAHL, CENTRAL, and Psychinfo were searched from inception––July 2013 for randomized controlled trials and controlled trials. Two authors independently assessed risk of bias and extracted data. Twenty-six studies were included (2740 participants). Interventions were delivered pre and during (n = 12), short-term (n = 8), and longer term (18 months) (n = 5) after primary treatment. No interventions were delivered beyond this time. Few trials recruited ethnic minorities and none recruited men in same sex relationships. Intervention components included information, education, health professional discussion, homework, peer discussion, buddy support, cognitive behavioral therapy, cognitive restructuring, psychoeducation, Reiki and relaxation. Most interventions were delivered for 5–10 weeks. Risk of bias of trials was assessed as unclear for most domains due to lack of information. The majority of trials measuring quality of life and depression found no effect. Relatively few trials measured anxiety, coping skills and self-efficacy, and the majority found no effect. No cost data were available. Trials of supportive care for men with prostate cancer cover a range of interventions but are limited by population diversity, inconsistent measurement and reporting of outcomes, and inability to assess risk of bias. Recommendations on design and conduct of future trials are presented.

Keywords:
Critical appraisal; prostate cancer; randomized controlled trials; supportive care; systematic review


Autoři: Theresa Helen Mazzarello Moore;  Anna Jyoti Louise King;  Maggie Evans;  Debbie Sharp;  Raj Persad;  Alyson Louise Huntley
Působiště autorů: Academic Unit of Primary Care, School of Social and Community Medicine, University of Bristol, Canynge Hall, Bristol BS8 2PA, UK
Vyšlo v časopise: Cancer Medicine 2015; 4(8)
Kategorie: Original Research
prolekare.web.journal.doi_sk: https://doi.org/10.1002/cam4.446

© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Souhrn

Abstract:
Men with prostate cancer are likely to have a long illness and experience psychological distress for which supportive care may be helpful. This systematic review describes the evidence for effectiveness and cost-effectiveness of supportive care for men with prostate cancer, taking into account treatment pathway and components of interventions. MEDLINE, EMBASE, CINAHL, CENTRAL, and Psychinfo were searched from inception––July 2013 for randomized controlled trials and controlled trials. Two authors independently assessed risk of bias and extracted data. Twenty-six studies were included (2740 participants). Interventions were delivered pre and during (n = 12), short-term (n = 8), and longer term (18 months) (n = 5) after primary treatment. No interventions were delivered beyond this time. Few trials recruited ethnic minorities and none recruited men in same sex relationships. Intervention components included information, education, health professional discussion, homework, peer discussion, buddy support, cognitive behavioral therapy, cognitive restructuring, psychoeducation, Reiki and relaxation. Most interventions were delivered for 5–10 weeks. Risk of bias of trials was assessed as unclear for most domains due to lack of information. The majority of trials measuring quality of life and depression found no effect. Relatively few trials measured anxiety, coping skills and self-efficacy, and the majority found no effect. No cost data were available. Trials of supportive care for men with prostate cancer cover a range of interventions but are limited by population diversity, inconsistent measurement and reporting of outcomes, and inability to assess risk of bias. Recommendations on design and conduct of future trials are presented.

Keywords:
Critical appraisal; prostate cancer; randomized controlled trials; supportive care; systematic review


Zdroje

1. Ferlay, J., H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127:2893–2917.

2. Hsing, A. W., L. Tsao, and S. S. Devesa. 2000. International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer 85:60–67.

3. Bray, F., J. Lortet-Tieulent, J. Ferlay, D. Forman, and A. Auvinen. 2010. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur. J. Cancer 46:3040–3052.

4. National Institute of Cancer. 2014. National Institute of Cancer USA definition of supportive care. Available at http://www.cancer.gov/dictionary?cdrid=46609 on the (accessed 21 July 2014).

5. Vieira, I., L. Burke, and D. Marks-Maran. 2014. Prostate cancer follow-up needs: do patients and professionals agree? Br. J. Nurs. 23:S12, S14–S19.

6. Cockle-Hearne, J., F. Charnay-Sonnek, L. Denis, H. E. Fairbanks, D. Kelly, S. Kav, et al. 2013. The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries. Br. J. Cancer 109:2121–2130.

7. Cockle-Hearne, J., and S. Faithfull. 2010. Self-management for men surviving prostate cancer: a review of behavioural and psychosocial interventions to understand what strategies can work, for whom and in what circumstances. Psychooncol 19:909–922.

8. Chambers, S. K., M. K. Hyde, A. M. Au, D. Ip, D. Shum, and J. Dunn. 2013. A systematic review of psycho-oncology research in Chinese populations: emerging trends. Eur. J. Cancer Care (Engl.) 22:824–831.

9. Chien, C. H., K. L. Liu, H. T. Chien, and H. E. Liu. 2014. The effects of psychosocial strategies on anxiety and depression of patients diagnosed with prostate cancer: a systematic review. Int. J. Nurs. Stud. 51:28–38.

10. Parahoo, K., S. McDonough, E. McCaughan, J. Noyes, C. Semple, E. J. Halstead, et al. 2013. Psychosocial interventions for men with prostate cancer. Cochrane Database Syst. Rev. 12:CD008529.

11.The Cochrane Collaboration. 2014. Review Manager (RevMan) [Computer program]. Version 5.3. The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark.

12. Beard, C., W. B. Stason, Q. Wang, J. Manola, E. Dean-Clower, J. A. Dusek, et al. 2011. Effects of complementary therapies on clinical outcomes in patients being treated with radiation therapy for prostate cancer. Cancer 117:96–102.

13. Carmack Taylor, C. L., M. A. Smith, C. de Moor, A. L. Dunn, C. Pettaway, R. Sellin, et al. 2004. Quality of life intervention for prostate cancer patients: design and baseline characteristics of the active for life after cancer trial. Control. Clin. Trials 25:265–285.

14. Carmack Taylor, C. L., C. Demoor, M. A. Smith, A. L. Dunn, K. Basen-Engquist, I. Nielsen, et al. 2006. Active for Life After Cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psychooncology 15:847–862.

15. Carmack Taylor, C. L., C. de Moor, K. Basen-Engquist, M. A. Smith, A. L. Dunn, H. Badr, et al. 2007. Moderator analyses of participants in the Active for Life after cancer trial: implications for physical activity group intervention studies. Ann. Behav. Med. 33:99–104.

16. Johnson, J. E., L. M. Nail, D. Lauver, K. B. King, and H. Keys. 1988. Reducing the negative impact of radiation therapy on functional status. Cancer 61:46–51.

17. Johnson, J. E., D. R. Lauver, and L. M. Nail. 1989. Process of coping with radiation therapy. J. Consult. Clin. Psychol. 57:358–364.

18. Johnson, J. E. 1996. Coping with radiation therapy: optimism and the effect of preparatory interventions.Res. Nurs. Health 19:3–12.

19. Kim, Y., J. A. Roscoe, and G. R. Morrow. 2002. The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support. Care Cancer 10:416–421.

20. Loiselle, C. G., L. Edgar, G. Batist, J. Lu, and S. Lauzier. 2010. The impact of a multimedia informational intervention on psychosocial adjustment among individuals with newly diagnosed breast or prostate cancer: a feasibility study. Patient Educ. Couns. 80:48–55.

21. Mishel, M. H., M. Belyea, B. B. Germino, J. L. Stewart, D. E. Bailey Jr., C. Robertson, et al. 2002. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. Cancer 94:1854–1866.

22. Mishel, M. H., B. B. Germino, M. Belyea, J. L. Stewart, D. E. Bailey Jr., J. Mohler, et al. 2003. Moderators of an uncertainty management intervention: for men with localized prostate cancer. Nurs. Res. 52:89–97.

23. Parker, P. A., C. A. Pettaway, R. J. Babaian, L. L. Pisters, B. Miles, A. Fortier, et al. 2009. The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J. Clin. Oncol. 27:3169–3176.

24. Cohen, L., P. A. Parker, L. Vence, C. Savary, D. Kentor, C. Pettaway, et al. 2011. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom. Med. 73:218–225.

25. Gilts, C. D., P. A. Parker, C. A. Pettaway, and L. Cohen. 2013. Psychosocial moderators of presurgical stress management for men undergoing radical prostatectomy. Health Psychol. 32:1218–1226.

26. Templeton, H., and V. Coates. 2004. Evaluation of an evidence-based education package for men with prostate cancer on hormonal manipulation therapy. Patient Educ. Couns. 55:55–61.

27. Scura, K. W., W. Budin, and E. Garfing. 2004. Telephone social support and education for adaptation to prostate cancer: a pilot study. Oncol. Nurs. Forum 31:335–338.

28. Walker, L. M., A. J. Hampton, R. J. Wassersug, B. C. Thomas, and J. W. Robinson. 2013. Androgen deprivation therapy and maintenance of intimacy: a randomized controlled pilot study of an educational intervention for patients and their partners. Contemp. Clin. Trials 34:227–231.

29. Yung, P. M., S. Chui-Kam, P. French, and T. M. Chan. 2002. A controlled trial of music and pre-operative anxiety in Chinese men undergoing transurethral resection of the prostate. J. Adv. Nurs. 39:352–359.

30. Bailey, D. E., M. H. Mishel, M. Belyea, J. L. Stewart, and J. Mohler. 2004. Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nurs. 27:339–346.

31. Berglund, G., L. M. Petersson, K. R. Eriksson, and M. Häggman. 2003. “Between men”: patient perceptions and priorities in a rehabilitation program for men with prostate cancer. Patient Educ. Couns. 49:285–292.

32. Berglund, G., L. M. Petersson, K. C. Eriksson, I. Wallenius, A. Roshanai, K. M. Nordin, et al. 2007. “Between Men”: a psychosocial rehabilitation programme for men with prostate cancer. Acta Oncol. 46:83–89.

33. Giesler, R. B., B. Given, C. W. Given, S. Rawl, P. Monahan, D. Burns, et al. 2005. Improving the quality of life of patients with prostate carcinoma: a randomized trial testing the efficacy of a nurse-driven intervention.Cancer 104:752–762.

34. Lepore, S. J., and V. S. Helgeson. 1999. Psychoeducational support group enhances quality of life after prostate cancer. Cancer Res. Ther. Control 8:81–92.

35. Lepore, S. J., V. S. Helgeson, D. T. Eton, and R. Schulz. 2003. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 22:443–452.

36. Helgeson, V. S., S. J. Lepore, and D. T. Eton. 2006. Moderators of the benefits of psychoeducational interventions for men with prostate cancer. Health Psychol. 25:348–354.

37. Manne, S. L., D. W. Kissane, C. J. Nelson, J. P. Mulhall, G. Winkel, and T. Zaider. 2011. Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: a pilot study. J. Sex. Med. 8:1197–1209.

38. Weber, B. A., B. L. Roberts, M. Resnick, G. Deimling, J. A. Zauszniewski, C. Musil, et al. 2004. The effect of dyadic intervention on self-efficacy, social support, and depression for men with prostate cancer.Psychooncology 13:47–60.

39. Weber, B. A., B. L. Roberts, H. Yarandi, T. L. Mills, N. R. Chumbler, and C. Algood. 2007. Dyadic support and quality-of-life after radical prostatectomy. J. Mens Health Gend. 4:156–164.

40. Campbell, L. C., F. J. Keefe, C. Scipio, D. C. McKee, C. L. Edwards, and S. H. Herman et al. 2007. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills training. Cancer 109(2 suppl.):414–424.

41. Molton, I. R., S. D. Siegel, F. J. Penedo, J. R. Dahn, D. Kinsinger, L. N. Traeger, et al. 2008. Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity. J. Psychosom. Res. 64:527–536.

42. Penedo, F. J., J. R. Dahn, I. Molton, J. S. Gonzalez, D. Kinsinger, B. A. Roos, et al. 2004. Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer 100:192–200.

43. Penedo, F. J., I. Molton, J. R. Dahn, B. J. Shen, D. Kinsinger, L. Traeger, et al. 2006. A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding. Ann. Behav. Med. 31:261–270.

44. Traeger, L., F. J. Penedo, C. Benedict, J. R. Dahn, S. C. Lechner, N. Schneiderman, et al. 2013. Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors. Psychooncol 22:250–259.

45. Northouse, L. L., D. W. Mood, A. Schafenacker, J. E. Montie, H. M. Sandler, J. D. Forman, et al. 2007.Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer110:2809–2818.

46. Wallace, M., and S. Stroms. 2007. The needs of men with prostate cancer: results of a focus group study.Appl. Nurs. Res. 20:181–187.

47. King, A. J. L, M. Evans, T. H. M. Moore, C. Paterson, D. Sharp, and R. Persad, et al. 2015. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. Eur J Cancer Care (Engl). doi: 10.1111/ecc.12286. [Epub ahead of print]

48. Anderson, B., and S. Marshall-Lucette. 2013. African and Afro-Caribbean men's experiences of prostate cancer. Br. J. Nurs. 22:1296–1298, 1300–1302, 1304–1307.

49. Hart, T. L., D. W. Coon, M. A. Kowalkowski, K. Zhang, J. I. Hersom, et al. 2014. Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers. J. Sex. Med.11:2308–2317.

50. Chamie, K., L. Kwan, S. E. Connor, M. Zavala, J. Labo, and M. S. Litwin. 2012. The impact of social networks and partnership status on treatment choice in men with localized prostate cancer. BJU Int. 109:1006–1012.

51. Mills, E., P. Wu, J. Gagnier, D. Heels-Ansdell, and V. M. Montori. 2005. An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently. J. Clin. Epidemiol. 58:662–667.

52. Hartling, L., M. Ospina, Y. Liang, D. M. Dryden, N. Hooton, J. Krebs Seida, et al. 2009. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 10:09.

53. Turner, L., L. Shamseer, D. Altman, K. Schulz, and D. Moher. 2012. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst. Rev. 1:60.

54. Jayadevappa, R., S. B. Malkowicz, S. Chhatre, J. C. Johnson, and J. J. Gallo. 2012 Dec. The burden of depression in prostate cancer. Psychooncology 21:1338–1345.

55. Sharpley, C. F., V. Bitsika, and D. H. Christie. 2013. Do prostate cancer patients suffer more from depressed mood or anhedonia? Psychooncology 22:1718–1723.

56. http://www.comet-initiative.org/ accessed on 30th June 2014.

Štítky
Onkológia

Článok vyšiel v časopise

Cancer Medicine

Číslo 8

2015 Číslo 8
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#